Moderna's COVID-19 vaccine worked well in monkeys: Study

Jul 29, 2020, at 03:21 pm

Giving humanity yet another hope that a solution will be reached soon, US Biotech major  Moderna said its COVID-19 vaccine induced a robust immune response and prevented the coronavirus from replicating in the noses and lungs of monkeys.

Moderna announces phase 3 COVE Study of mRNA vaccine against COVID-19 begins 

Jul 28, 2020, at 03:07 pm

New York/IBNS: Moderna, Inc, a clinical stage biotechnology company, on Monday announced that the Phase 3 study of its mRNA vaccine candidate (mRNA-1273) against COVID-19 has begun dosing participants. 

Moderna coronavirus vaccine shows 'positive' phase 1 result

Jul 15, 2020, at 02:46 pm

Boston: A Coronavirus vaccine developed by  biotechnology company Moderna showed positive response in phase 1 study.

COVID-19: Moderna announces positive interim phase 1 data for its mRNA Vaccine

May 19, 2020, at 04:59 pm

New York/IBNS: Moderna, Inc.,  a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, has announced positive interim clinical data of mRNA-1273, its vaccine candidate against novel coronavirus (SARS-CoV-2), from the Phase 1 study led by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).